Rajeev Muni, an ophthalmologist and vice-chair of clinical research in the Department of Ophthalmology and Vision Sciences at the University of Toronto, told Fox News Digital
In practical portfolio terms, Novo is doing what the market rewards: prove the maximal efficacy franchise first in the route with the highest probability of success, then decide whether oral conversion is worth the additional complexity
Fleming DR et al, The Safety of Injecting Insulin Through Clothing
Age, as natural production tends to decrease as we get older
The authors demonstrate that GLP-1R agonist treatment induces expression of tyrosine kinase IGF1R/ErbB (EGFR) pathways, however, agonist treatment can still increase intestinal growth in the absence of intestinal epithelial IGF1 receptor as well as EGF receptor signaling (Koehler et al., 2015)